Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$726.31 19.64 (2.63%) as of 4:30 Fri 4/19


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 694.77(B)
Last Volume: 3,504,313 Avg Vol: 3,293,197
52 Week Range: $374.81 - $792.28
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 644,570 871,420 3,176,506 6,211,418
Total Sell Value $465,524,857 $608,633,217 $2,147,483,647 $2,147,483,647
Total People Sold 2 2 5 6
Total Sell Transactions 8 14 47 89
End Date 2024-01-21 2023-10-20 2023-04-21 2022-04-21

   
Records found: 3297
  Page 1 of 132  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Johnson Kimberly H Director   –       •      –    2024-04-15 4 A $750.77 $9,760 D/D 13 2,627     -
   Luciano Juan R Director   –       •      –    2024-04-15 4 A $750.77 $15,015 D/D 20 15,678     -
   Hedley Mary Lynne Director   –       •      –    2024-04-15 4 A $750.77 $9,760 D/D 13 1,477     -
   Greene Gabrielle E Director   –       •      –    2024-04-15 4 A $750.77 $9,760 D/D 13 2,128     -
   Alvarez Ralph Director   –       •      –    2024-04-15 4 A $750.77 $12,012 D/D 16 54,029     -
   Hedley Mary Lynne Director   –       •      –    2024-03-18 4 A $762.66 $9,915 D/D 13 1,464     -
   Johnson Kimberly H Director   –       •      –    2024-03-18 4 A $762.66 $9,915 D/D 13 2,614     -
   Greene Gabrielle E Director   –       •      –    2024-03-18 4 A $762.66 $9,915 D/D 13 2,115     -
   Alvarez Ralph Director   –       •      –    2024-03-18 4 A $762.66 $11,440 D/D 15 54,013     -
   Luciano Juan R Director   –       •      –    2024-03-18 4 A $762.66 $14,491 D/D 19 15,658     -
   Zakrowski Donald A SVP, Finance, & CAO   •       –      –    2024-03-11 4 AS $753.60 $565,200 D/D (750) 7,880 2%     
   Luciano Juan R Director   –       •      –    2024-02-20 4 A $755.66 $15,113 D/D 20 15,612     -
   Hedley Mary Lynne Director   –       •      –    2024-02-20 4 A $755.66 $9,824 D/D 13 1,449     -
   Johnson Kimberly H Director   –       •      –    2024-02-20 4 A $755.66 $9,824 D/D 13 2,597     -
   Alvarez Ralph Director   –       •      –    2024-02-20 4 A $755.66 $12,091 D/D 16 53,906     -
   Greene Gabrielle E Director   –       •      –    2024-02-20 4 A $755.66 $9,824 D/D 13 2,098     -
   Lilly Endowment Inc   –       –       •   2024-02-16 4 S $764.29 $132,521,930 D/D (169,684) 98,898,810 5%     
   Lilly Endowment Inc   –       –       •   2024-02-15 4 S $760.19 $38,263,417 D/D (50,316) 99,068,494 2%     
   Weems Alonzo EVP, ERM & CECO   •       –      –    2024-02-12 4 A $737.26 $701,134 D/D 951 7,951     -
   Dozier Eric EVP, HR & Diversity   •       –      –    2024-02-12 4 A $737.26 $984,979 D/D 1,336 7,190     -
   Dozier Eric EVP, HR & Diversity   •       –      –    2024-02-12 4 GD $0.00 $0 D/D 408 5,854     -
   Ashkenazi Anat EVP & CFO   •       –      –    2024-02-12 4 A $737.26 $3,103,865 D/D 4,210 42,330     -
   Zakrowski Donald A SVP, Finance, & CAO   •       –      –    2024-02-12 4 A $737.26 $924,524 D/D 1,254 8,630     -
   Yuffa Ilya EVP & President, LLY Intl   •       –      –    2024-02-12 4 A $737.26 $3,531,475 D/D 4,790 19,802     -
   Van Naarden Jacob EVP & Pres., Loxo@Lilly   •       –      –    2024-02-12 4 A $737.26 $1,746,569 D/D 2,369 16,147     -
  3297 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 132
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us